Diurnal Group PLC Correction: Director Dealings (4562Y)

TIDMDNL

RNS Number : 4562Y

Diurnal Group PLC

13 May 2021

13 May 2021

Diurnal Group plc

("Diurnal" or the "Company")

Correction: Director Dealings

This is a correction to the Director Dealings announcement published at 3:44 p.m. on 12 May 2021 (RNS number 4297Y) which has been amended with the correct total beneficial interests of Sam Williams, Interim Chairman and Richard Bungay, Chief Financial Officer each of 0.07% of the total voting rights.

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that further to the Capital Raising, details of which were announced on 21 April 2021 and Admission, the following Directors' dealings as part of the Subscription and Open Offer have completed:

Sam Williams, Interim Chairman, subscribed for 28,571 Ordinary Shares at a price of 70 pence per Ordinary Share.

Martin Whitaker, Chief Executive Officer, subscribed for a total of 10,000 Ordinary Shares at 70 pence per share, including 6,000 shares to be held in pension schemes for the beneficial interest of his dependent children.

Richard Bungay, Chief Financial Officer, subscribed for 7,143 Ordinary Shares at a price of 70 pence per Ordinary Share.

John Goddard, Non-Executive Director, subscribed for 28,571 Ordinary Shares at a price of 70 pence per Ordinary Share.

Following Admission, the total beneficial interest of Sam Williams is 113,819 Ordinary Shares, representing 0.07% of the total voting rights, Martin Whitaker and his connected parties is 603,823 Ordinary Shares, representing 0.36% of the total voting rights, the total beneficial interest of Richard Bungay is 114,252 Ordinary Shares, representing 0.07% of the total voting rights and the total beneficial interest of John Goddard is 228,674 Ordinary Shares, representing 0.14% of the total voting rights.

The capitalised terms used in this announcement have the same meanings as in the announcement published by the Company at 7.00 a.m. on 21 April 2021 unless otherwise stated.

Details of the full notifications received by the Company are set out below:

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Names                                    Sam Williams 
                                                 Martin Whitaker and dependent children 
                                                 Richard Bungay 
                                                 John Goddard 
      ---------------------------------------  --------------------------------------------- 
 2     Reason for the notification 
      -------------------------------------------------------------------------------------- 
 a)    Position/status                          Interim Chairman 
                                                 Chief Executive Officer 
                                                 Chief Financial Officer 
                                                 Non-Executive Director 
      ---------------------------------------  --------------------------------------------- 
 b)    Initial notification                     Initial notification 
        /Amendment 
      ---------------------------------------  --------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      -------------------------------------------------------------------------------------- 
 a)    Name                                     Diurnal Group plc 
      ---------------------------------------  --------------------------------------------- 
 b)    LEI                                      213800I2HNUNZN1LDH29 
      ---------------------------------------  --------------------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      -------------------------------------------------------------------------------------- 
 a)    Description of the                       Ordinary Shares of 5 pence each in 
        financial instrument,                    Diurnal Group plc 
        type of instrument 
 
       Identification code                      GB00BDB6Q760 
 
 b)    Nature of the transaction                Purchase of Ordinary Shares 
      ---------------------------------------  --------------------------------------------- 
 c)    Price(s) and volume(s) 
                                                --------------------  -------------------- 
                                                 Price(s)              Volume(s) 
                                                --------------------  -------------------- 
                                                 70p                   28,571 
                                                --------------------  -------------------- 
                                                 70p                   10,000 
                                                --------------------  -------------------- 
                                                 70p                   7,143 
                                                --------------------  -------------------- 
                                                 70p                   28,571 
                                                --------------------  -------------------- 
 
 d)    Aggregated information 
 
  - Aggregated volume                      n/a 
 
  - Price 
 
 e)    Date of the transaction                  11 May 2021 
      ---------------------------------------  --------------------------------------------- 
 f)    Place of the transaction                 XLON 
      ---------------------------------------  --------------------------------------------- 
 
 
 For further information, please visit www.diurnal.co.uk or 
  contact: 
 
                                                   [phone] 
 Diurnal Group plc                                  1000 
 Martin Whitaker, Chief Executive Officer 
 Richard Bungay, Chief Financial Officer 
 
 Panmure Gordon (UK) Limited (Nominated Adviser    [phone] 
  and Sole Broker)                                  2500 
 Corporate Finance: Freddy Crossley, Emma Earl 
 Corporate Broking: Rupert Dearden 
 
                                                   [phone] 
 FTI Consulting (Media and Investor Relations)      1000 
 Simon Conway 
 Victoria Foster Mitchell 
 Alex Davis 
 

Notes to Editors

About Diurnal Group plc

Diurnal Group plc is a European, UK-headquartered, specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism and hypothyroidism. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visit www.diurnal.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBCGDUXDBDGBD

(END) Dow Jones Newswires

May 13, 2021 02:00 ET (06:00 GMT)